n.petrov

TL2 · Recife

Contributes reviews on supplier material. Based in Recife.

Joined 4 August 2025 · last posted 2d

70Posts here

3Topics

0Solutions

648Likes received

706Likes given

18Badges

156Days visited

2.5kPosts read

Recent activity

Full stream

Journal club: what we got wrong in an earlier session Replied, post #122 · Evidence › Journal club · 26 Jul 2026 · 5 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
Revisiting: The best-written scientific paper you have read Replied, post #98 · Lounge › Off topic · 17 Jul 2026 · 0 likes The most useful reply I ever got about best-written scientific paper was a request to state my units. It sounds like pedantry and it has saved me twice.
Reading a home test result without over-claiming Replied, post #123 · Analytics › Home & field testing · 17 Jul 2026 · 8 likes Weighing vials against declared fill is the most underrated home check available. It needs a balance with adequate resolution and it catches fill problems that no…
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #55 · Practice › Side effects · 17 Jul 2026 · 26 likes Second this, and I would have said it less carefully.
Tracking a shortage from primary sources rather than rumour Replied, post #102 · Access › Shortages · 14 Jul 2026 · 0 likes Everything in post #100 holds. The case it does not cover is the one I have. The most useful contribution is a link to the current official notice rather than an…
Manufacturer assistance programmes and their eligibility rules Replied, post #42 · Access › Pricing · 13 Jul 2026 · 2 likes Second this, and I would have said it less carefully.
What is genuinely unknown about long-term amylin agonism Replied, post #33 · Compounds › Cagrilintide & amylin analogues · 13 Jul 2026 · 15 likes On storage: aggregation-prone peptides are the ones where repeated warming and cooling does the most damage, and where a solution that looks fine may already have…
Pooling trials with different estimands Replied, post #86 · Evidence › Meta-analyses · 10 Jul 2026 · 15 likes Right — I had this wrong and I am glad to have read it before it mattered.
Second pass at: Reading a trial's population section before its results Replied, post #2 · Evidence › Trials · 28 Jun 2026 · 21 likes The estimand: what the trial set out to estimate. Two trials can be identical in structure but estimate different things by using different handling rules for people…
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #31 · Sourcing › Independent verification · 21 Jun 2026 · 25 likes Second this, and I would have said it less carefully.
Follow-up: Prior authorisation: what the criteria usually require Replied, post #15 · Access › Insurance & coverage · 11 Jun 2026 · 0 likes Post #14 is the version of this I will quote in future. One addition. What does not work: describing how the decision made you feel, however justified. The reviewer is…
Coming back to: Time to steady state after a dose increase Replied, post #72 · Pharmacology › Pharmacokinetics · 9 Jun 2026 · 0 likes Between-person variability in exposure is substantial and is the reason two people on the same dose can have quite different plasma concentrations. That is inherent…